Supernus Pharmaceuticals, Inc.

This study is testing whether adding an experimental drug called SPN-821 to standard antidepressant medication helps adults with major depressive disorder. Researchers will enroll 230 participants who are currently taking antidepressants but still experiencing significant depress…

This study is observing how 120 people with Parkinson's disease use a new, wearable pump that continuously delivers a medication called apomorphine under the skin. The goal is to understand the real-world experience of using this device, including how long it takes to find the ri…

This study follows up on previous research to test SPN-817's long-term safety and effectiveness in controlling seizures over one year. It involves 100 adults with focal onset seizures who previously participated in an SPN-817 study. Participants will receive the medication for a …

This study is testing whether a medication called SPN-812 (viloxazine) is safe and effective at reducing symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in very young children. It will involve about 286 children aged 4 to 5 years old. The children will take the medica…